Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma

Stefania Maraka, Morris D. Groves, Marta Penas-Prado

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma'. Together they form a unique fingerprint.